These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 2153010)

  • 41. Detection of breast carcinoma: comparison of automated water-path whole-breast sonography, mammography, and physical examination.
    Egan RL; Egan KL
    AJR Am J Roentgenol; 1984 Sep; 143(3):493-7. PubMed ID: 6331727
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Analysis of clinically occult and mammographically occult breast tumors.
    Feig SA; Shaber GS; Patchefsky A; Schwartz GF; Edeiken J; Libshitz HI; Nerlinger R; Curley RF; Wallace JD
    AJR Am J Roentgenol; 1977 Mar; 128(3):403-8. PubMed ID: 190908
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enhanced detection of preinvasive breast cancer: combined role of mammography and needle localization biopsy.
    Molloy M; Azarow K; Garcia VF; Daniel JR
    J Surg Oncol; 1989 Mar; 40(3):152-4. PubMed ID: 2537442
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nonpalpable breast lesions: diagnosis with slightly overpenetrated screen-film mammography and hook wire-directed biopsy in 1,014 cases.
    Silverstein MJ; Gamagami P; Colburn WJ; Gierson ED; Rosser RJ; Handel N; Waisman JR
    Radiology; 1989 Jun; 171(3):633-8. PubMed ID: 2717734
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Needle localization and biopsy of nonpalpable lesions of the breast.
    Landercasper J; Gundersen SB; Gundersen AL; Cogbill TH; Travelli R; Strutt P
    Surg Gynecol Obstet; 1987 May; 164(5):399-403. PubMed ID: 3576416
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinically occult breast lesions: localization and significance.
    Rosenberg AL; Schwartz GF; Feig SA; Patchefsky AS
    Radiology; 1987 Jan; 162(1 Pt 1):167-70. PubMed ID: 3024209
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Randomized controlled clinical trial comparing radioguided occult lesion localization with wire-guided lesion localization to evaluate their efficacy and accuracy in the localization of nonpalpable breast lesions.
    Duarte C; Bastidas F; de los Reyes A; Martínez MC; Hurtado G; Gómez MC; Sánchez R; Manrique J
    Surgery; 2016 Apr; 159(4):1140-5. PubMed ID: 26549819
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nonpalpable breast cancer: a mammographic-histological correlation.
    Egense M; Brünner S; Hansen H; Jacobsen GK; Laursen N
    Recent Results Cancer Res; 1990; 119():116-21. PubMed ID: 2173081
    [No Abstract]   [Full Text] [Related]  

  • 49. Management of patients with nonpalpable breast lesions.
    Schwartz GF; Feig SA
    Oncology (Williston Park); 1991 Oct; 5(10):39-44; discussion 47-8, 50. PubMed ID: 1838272
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Breast cancer detection with sonography and mammography: comparison using state-of-the-art equipment.
    Sickles EA; Filly RA; Callen PW
    AJR Am J Roentgenol; 1983 May; 140(5):843-5. PubMed ID: 6601422
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Staging and treatment of clinically occult breast cancer.
    Schwartz GF; Feig SA; Rosenberg AL; Patchefsky AS; Schwartz AB
    Cancer; 1984 Mar; 53(6):1379-84. PubMed ID: 6692326
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Correlation between mammography and the pathology of nonpalpable breast lesions.
    Albert MP; Sachsse E; Coe NP; Page DW; Reed WP
    J Surg Oncol; 1990 May; 44(1):44-6. PubMed ID: 2342374
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Needle localization in occult breast lesions.
    Landstrom J; Osgood G; Young SC
    J Surg Oncol; 1989 Jan; 40(1):1-3. PubMed ID: 2909802
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Implications of suspicious findings in breast cancer screening.
    Lewis JD; Milbrath JR; Shaffer KA; Das Gupta TK
    Arch Surg; 1975 Aug; 110(8):903-7. PubMed ID: 168837
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Radio-pathological correlation of occult tumor of the breast.
    Janus CL; Hermann G
    Crit Rev Diagn Imaging; 1984; 23(1):41-73. PubMed ID: 6100176
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Analysis of mammographically obvious carcinomas of the breast with benign results upon initial biopsy.
    Meyer JE; Kopans DB
    Surg Gynecol Obstet; 1981 Oct; 153(4):570-2. PubMed ID: 6269239
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Automated water-path full-breast sonography: correlation with histology of 176 solid lesions.
    Egan RL; Egan KL
    AJR Am J Roentgenol; 1984 Sep; 143(3):499-507. PubMed ID: 6087645
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Open surgical biopsy for nonpalpable breast lesions detected on screening mammography.
    Markopoulos C; Kouskos E; Revenas K; Mantas D; Antonopoulou Z; Kontzoglou K; Nikiteas N; Kyriakou V
    Eur J Gynaecol Oncol; 2005; 26(3):311-4. PubMed ID: 15991535
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The clinical significance of minimal breast cancer: a pathologist's viewpoint.
    Wirman JA
    Crit Rev Oncol Hematol; 1985; 3(1):35-74. PubMed ID: 2990747
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nonpalpable breast lesions: association of mammographic abnormalities with diagnosis after needle-directed biopsy.
    Bowers GJ; Getz JB; Roettger RH; Gaines CE; Beck DE
    South Med J; 1993 Jul; 86(7):748-52. PubMed ID: 8391719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.